Triple-negative breast cancer is an aggressive form of breast cancer, and recent studies have identified the genes that are associated with an increased risk of this disease. By identifying genetic risk factors earlier on, it’s possible for women to have better outcomes.

SurvivorNet spoke with Kathie-Ann Joseph, MD, MPH, associate professor of surgery and population health at Perlmutter Cancer Center, for her take on genetic testing for breast cancer. “We need to test more women,” says Dr. Joseph. “It’s important to identify women who are at risk for triple-negative breast cancer, and if you’re diagnosed with breast cancer, it’s important to understand that you should be tested for other genes apart from BRCA1 and BRCA2.”

Watch more on SurvivorNet.